Despite its effectiveness for the facial rejuvenation, blepharoplasty has been associated with several adverse effects. One of the most common side effects of this surgery is eyelid malposition and scleral show which is not suitable from esthetic point of view. Although some techniques have been used for the blepharoplasty of the lower eyelid, the effect of these techniques has not been defi nitely identifi ed in the incidence of scleral show. The present study compared the effects of lower eyelid blepharoplasty with transconjunctival and transcutaneous approaches in the incidence of scleral show in patients. 22 candidates of the lower eyelid blepharoplasty were studied. The patients had no history of systemic disease, previous lower eyelid blepharoplasty, trauma or dry eye syndrome. The patients were randomly assigned in 2 methods of transconjunctival and transcutaneous approaches. The surgeries were perform on 2 eyelids of the left and right sides and in total, 44 eyelids were subjected to blepharoplasty surgery in both sides of the patients in 2 approaches. The incidence of scleral show in both modalities was studied 2, 4 and 6 months post-surgery. In this study, 22 patients were included for eyelid blepharoplasty (44 eyelids). In the transconjuctival approach, 4 males and 7 females with average age of the 57.09 years old were included. For transcutaneous approach, 5 males and 5 females average age of the 56.18 years old were included. According to the results, no scleral was showed using transconjuctival approach after 2 months. Two months after transcutaneous approach only 2 (9%) scleral was observed (P<0.8 signifi cant difference detected in scleral using transconjuctival or transcutaneous operations after 4 months, however only 2 (9%) scleral was observed using transcutaneous approach (P<0.8). The same results observed after 6 months follow-up period (P<0.8).Despite insignifi cant differences between 2 lower eyelid blepharoplasty approaches regarding the scleral show incidence, using transconjunctival technique was recommended for the lower eyelid blepharoplasty in order to decrease the incidence of the scleral show.
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INTRODUCTION
Blepharoplasty remains one of the most common contemporary facial surgical procedures performed. While in oculo-facial plastic surgery functional upper eyelid blepharoplasty still encompasses the majority of the specialties procedures, cosmetic upper and lower blepharoplasty are rapidly increasing in number.The skin-muscle fl ap approach to lower blepharoplasty was popularized in the 1970s. It remained the most generally used method because of e fast, effective and widely applicable (Hidalgo, 2011; Massry and Hartstein, 2012) . Post blepharoplasty treatment of lower eyelid retraction is challenging (Yoo et al. 2013) . Several methods introduced to improve lower eyelid blepharoplasty outcome (Schwarcz et al. 2016 , Kossler et al. 2017 .
Transcutaneous lower eyelid blepharoplasty with fat excision has been the paradigm for addressing the undesirable sequelae of the aging eye . This is eyelid contour and no changes in eyelid position when performed in a conservative fashion. Transcutaneous is a time-tested method that achieves satisfactory cosmetic results (Garcia and McCollough, 2006) . The latest evolution of the transcutaneous lower eyelid blepharoplasty is a skin fl ap or skin muscle fl ap method in which the incision is placed inferiorly to the tarsal margin (Freeman, 2000) . The transconjunctival approach was primary described in 1924 to the lower orbital fat and the inferior orbital surface (Korchia et al. 2003) . Transconjunctival lower eyelid blepharoplasty is most acceptable as a safe and effective method to eliminate herniated orbital fat from the lower eyelid and avoiding the complications of a cutaneous incision (Belinsky et al. 2015) .
The transconjunctival approach avoids numerous complications of the classic transcutaneous lower blepharoplasty (Kossler et al. 2017) . It is reported the limitations of the transcutaneous approach was improved by the transconjunctival approach (LoPiccolo et al. 2013) . The transconjunctival approach has gained popularity over the transcutaneous approaches because of its inconspicuous scar and decreased risk of postoperative ectropion and scleral show (Salhi and Cordoba, 2015) .
Scleral show is one of the main complications of lower blepharoplasty which may result to manifest as lack of defi nition of the lateral part of the eyes and eyelid retraction (Pascali et al. 2015) . Lower eyelid retraction is known for the existence of scleral show (which each patient stated ). Scleral show is one of the most feared complications of lower blepharoplasty surgery. The attendant scleral show and rounding of the eye are poorly tolerated by patients from a cosmetic and often functional stand-point (Griffi n et al. 2014). The surgical correction of postsurgical eyelid retraction can be challenging as well as frustrating (Yoo et al. 2014) .
Despite its effectiveness for the facial rejuvenation, blepharoplasty has been associated with several adverse effects. One of the most common side effects of this surgery is eyelid malposition and scleral show which is not suitable from esthetic point of view. Although some techniques have been used for the blepharoplasty of the lower eyelid, the effect of these techniques has not been definitely identifi ed in the incidence of scleral show. So, the current study was compared the effects of lower eyelid blepharoplasty with transconjunctival and transcutaneous approaches in the incidence of scleral show in patients.
MATERIAL AND METHODS
In a prospective randomized clinical trial, 22 candidates of the lower eyelid blepharoplasty in patients referred to two private clinics and Bu Ali hospital at 2015. The patients had no history of systemic disease, previous lower eyelid blepharoplasty, trauma or dry eye syndrome. The patients were randomly assigned in 2 methods of transconjunctival and transcutaneous approaches. The surgeries were perform on 2 eyelids of the left and right sides and in total, 44 eyelids were subjected to blepharoplasty surgery in both sides of the patients in 2 approaches. The incidence of scleral show in both modalities was studied using standard photographs of patients taken before the surgery and 2, 4 and 6 months post-surgery. The frequency of the scleral show was statistically analyzed by exact fi sher test in two approaches in different time intervals.
RESULTS
In this study, 22 patients were included for eyelid blepharoplasty (44 eyelids). In the transconjuctival approach, 4 males and 7 females with average age of the 57.09 years old were included. For transcutaneous approach, 5 males and 5 females average age of the 56.18 years old were included. Then all patients were followed-up 6 months for possible scleral show (table 1) .
BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS COMPARISON OF TWO TRANSCONJUNCTIVAL AND TRANSCUTANEOUS APPROACHES
The results of the scleral show at 2-6 months post transconjuctival or transcutaneous operations are presented in table 2. According to the results, no scleral was showed using transconjuctival approach after 2 months. Two months after transcutaneous approach only 2 (9%) scleral was observed (P<0.8). No signifi cant difference detected in scleral using transconjuctival or transcutaneous operations after 4 months, however only 2 (9%) scleral was observed using transcutaneous approach (P<0.8). The same results observed after 6 months follow-up period (P<0.8).
DISCUSSION
Eyelid tone, position and scleral show have been the most common limiting aspects of lower blepharoplasty. Dysfunction of the lateral canthal tendon can be caused by aging, iatrogenic damage, and so on (Sacchidanand et al. 2012) . Lower eyelid retraction might occur by dynamic imbalance in the lateral suspension system of the lower eyelid, lack of elasticity of mid facial soft tissue and etc. (Oestreicher and Mehta, 2012) . Base on the results of the current study, no scleral was showed using transconjuctival approach after 2 months. Two months after transcutaneous approach only 2 (9%) scleral was observed. No signifi cant difference detected in scleral using transconjuctival or transcutaneous operations after 4 months, however only 2 (9%) scleral was observed using transcutaneous approach. The same results observed after 6 months follow-up period. In this regard, Bernardino et al. (2016) reported there was improvement in all 16 female and 2 male patients in the appearance of increased the lower eyelid and reduction in skin and lateral ligament laxity. Also, eyelid retraction, ectropion, unaesthetic scars, diplopia and remnant fat bags were not observed (Bernardino et al. 2016) .
During the 1998-2008 in 2400 patients underwent lower blepharoplasty Transconjunctival blepharoplasty was the fi rst choice for primary eyelid bags. Transcutaneous lower blepharoplasty (skin fl ap or skin-muscle fl ap procedures) is indicated for the senile eyelid with excess skin and muscles (Guo et al. 2010) .Both transconjunctical and transcutaneous approaches is applied for upper and lower lid blepharoplasty. Even though transcutaneous upper and lower eyelid surgery and transconjunctival lower lid procedures are popular with facial plastic surgeons, transconjunctival upper blepharoplasty is new technique with limited indications (Jacono et al. 2001) . These researchers suggested the transconjunctival lower lid blepharoplasty as it circumvents the risk of lower eyelid retraction associated with the transcutaneous approach (Jacono et al. 2001) . A lower rate of complications reported via the transconjunctival approach, with greater patient satisfaction (Rancati et al. 2015) .
The transconjunctival and approaches were preferred in 42 and 58 % (Rancati et al. 2015) . In transconjunctival versus transcutaneous lower eyelid blepharoplasty (Netscher et al. 1995) in 6 months follow-up reported 10 consecutive patients presented for blepharoplasty, and in all patients the transcutaneous subciliary musculocutaneous fl ap approach was used on the left lower eyelid and the transconjunctival preseptal approach was used on the right. No signifi cant variance on the 2 sides (0.60 on the left and 0.68 on the right) (Netscher et al. 1995) . No signifi cant difference reported in lower eyelid position change between the transconjunctival lower blepharoplasty with versus without a skin pinch groups. Using the transcutaneous approach, the presented infection FIGURE 1. Results of the transconjunctival apporeach (left) and transcutaneous (right) FIGURE 2. Results of the transconjunctival apporeach before and after the surgery FIGURE 3. Results of the transcutaneous apporeach before and after the surgery (2%), scleral show (2%) and insuffi cient skin resection (1%) was reported (Hidalgo, 2011) . The transconjunctival approach is an ideal procedure due to its simplicity and less traumatic effect, except in the lower eyelid weakness and surgical resolution (Collar et al. 2013) . In conclusion, despite insignifi cant differences between 2 lower eyelid blepharoplasty approaches regarding the scleral show incidence, using transconjunctival technique was recommended for the lower eyelid blepharoplasty in order to decrease the incidence of the scleral show.
